Visit Our Other Websites
empty
empty
CORONAVIRUS (COVID-19) RESOURCE CENTER Read More

TX HB 3717

Title: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Author: Gary VanDeaver

Summary

Status
Laid on the table subject to call

Bill Documents
TX HB 3717 - Introduced
2025-03-04 - TX HB 3717 (Introduced)

TX HB 3717 - House Committee Report
2025-03-04 - TX HB 3717 (House Committee Report)
TX HB 3717 - Introduced
2025-03-04 - TX HB 3717 (Introduced)

Add To Favorites

Author Details